HIGHLIGHTS
- who: Nobuhiro Nagai from the Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Sendai, Japan have published the research: Release of ranibizumab using a porous poly(dimethylsiloxane) capsule suppressed laser-induced choroidal neovascularization via the transscleral route, in the Journal: (JOURNAL)
- what: We produced a novel controlled-release device fabricated by salt-leaching of a micro-sectioned PDMS sheet containing salt microparticles.
- how: The results indicated that the transscleral administration route could be an alternative to intravitreal injections.
SUMMARY
The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.